Vulvovaginal Candidiasis and Vulvovaginitis Among Women of Reproductive Age in Colombia: Insights from the Integrated Information System of Social Protection
Abstract
Vaginal infections remain a leading cause of gynecological visits worldwide, with yeastrelated
infections increasing among women of reproductive age. This study aims to determine the prevalence of vulvovaginal candidiasis and vulvovaginitis among Colombian women of reproductive age between 2015 and 2019. Conducted as a descriptive, cross-sectional study, the research utilized data from the Individual Records of Health Services Provision database of the Ministry of Health of Colombia. Between January 1st, 2015, and December 31st, 2019, a total of 2,384,164 cases of vulvovaginal candidiasis and vulvovaginitis were treated in Colombian women of reproductive age. The national
prevalence was estimated at 18.6 per 100 women of reproductive age, with higher prevalence observed in the departments of Córdoba, Huila, Cauca, Cesar, and Nariño. This prevalence aligns with the regional average for Latin American countries, posing a significant threat to reproductive health. Consequently, there is an urgent need to implement preventive measures, mitigate risk factors, and reduce the incidence of these infections among women of reproductive age.
Downloads
References
Salvi M. Prevalence of vulvovaginal candidiasis in females in the reproductive age group. Int J Reprod Contracept Obstet Gynecol 2019; 8(2):647-651. http://dx.doi.org/10.18203/2320-1770.ijrcog20190299
Kalia N, Singh J, Sharma S, Kamboj SS, Arora H, Kaur M. Prevalence of Vulvovaginal Infections and Species Specific Distribution of Vulvovaginal Candidiasis in Married Women of North India. Int J Curr Microbiol App Sci 2015; 4(8):253-66. http://www.ij.cmas.com
Solís-Arias MP, et al. Colonización vaginal por Candida spp. Frecuencia y descripción de las especies aisladas.Ginecol Obstet Mex [Internet]. 2014;82:1-8. Disponible en: https://www.medigraphic.com/pdfs/ginobsmex/gom-2014/gom141b.pdf
Ciudad-Reynaud A. Infecciones vaginales por cándida:diagnóstico y tratamiento. Rev Per Ginecol Obstet [Internet]. 2007;53(3):159-166. Disponible en: https://sisbib.unmsm.edu.pe/bvrevistas/ginecologia/vol53_n3/pdf/a04v53n3.pdf
Valencia-Arredondo M, Yepes-López WA. Prevalencia y factores asociados con vaginosis bacterianas, candidiasis y tricomoniasis en dos hospitales de los municípios de Apartadó y Rionegro Antioquia, 2014. Iatreia 2018; 31(2):133-4.http://dx.doi.org/10.17533/udea.iatreia.v31n2a02
Arango Garzón JS, Valencia Arredondo M, Cardona-Arias JA. Factores Clínicos y Sexuales Asociados con vaginosis Bacteriana, Cándida spp y Trichomonas spp. en una Institución Prestadora de Servicios de Salud de Medellín Colombia. Arch Med 2018; 14(2):1-9. http://dx.doi.org/10.3823/1391
Gonçalves B, Ferreira C, Alves CT, Henriques M, Azeredo J, Silva S. Vulvovaginal candidiasis: Epidemiology, microbiology and risk factors. Crit Rev Microbiol 2016; 42(6):905-27. http://dx.doi.org/10.3109/1040841X.2015.1091805
Pineda-Murillo J, Cortés-Figueroa A, Uribarren-Berrueta TNJ, Castañón Olivares LR. Candidosis vaginal. Revisión de la literatura y situación de México y otros países latinoamericanos. Rev Méd Risaralda 2017;23(1):38-44.
Barraza NL, et al. Características clínicas de vulvovaginitis por Candida albicans en mujeres en edad reproductiva. Rev Peru Investig Matern Perinat [Internet].2019;8(1):8-12. http://dx.doi.org/10.33421/inmp.2019133
Sánchez J, et al. Prevalencia de Candida albicans y su relación con cambios en el pH vaginal. Aten Fam [Internet]. 2017;24(1):18-22. http://dx.doi.org/10.1016/j.af.2017.01.003
Delmonte ML, et al. Frecuencia del género Candida en vagina de mujeres en edad reproductiva. Kasmera 2017;45(1):44-51.
Martinez Brandolt T, et al. Prevalence of Candida spp. in Cervical-Vaginal Samples and the In Vitro Susceptibility of Isolates. Braz. J. Microbiol [Internet].2017;48(1):145-150. http://dx.doi.org/10.1016/j.bjm.2016.09.006
Jacob L, et al. Prevalence of Vulvovaginal Candidiasis in Gynecological Practices in Germany: A Retrospective Study of 954,186 Patients. Curr Med Mycol [Internet]. 2018;4(1):6-11. http://dx.doi.org/10.18502/cmm.4.1.27
Chuku A, Yami AL, Bukola A. Prevalence of Candida Species from Cases of Vulvovaginitis in Women using Contraceptives in Four Selected States of North Central Nigeria. JAMB [Internet]. 2019;18(3):1-10. http://dx.doi.org/10.9734/jadmb/2019/v18i330174
Siddiqui R. Clinical Patterns and Risk Factors of Vulvo-Vaginal Candidiasis Among Women of Reproductive Age Attending a Tertiary Hospital in Central India. Staf J Microbiol [Internet]. 2019;9(1):27-31. http://dx.doi.org/10.3329/sjm.v9i1.45655
Bhargava D, et al. Prevalence of Vaginitis in Females Attending National Medical College and Teaching Hospital, Birgunj, Nepal. Indian J. Med Res. Pharm. Sci[Internet]. 2016;3(7):39-43. http://dx.doi.org/10.5281/zenodo.58909
Habibipour R. Prevalence Rate of Vulvovaginal Candidiasis and Identification of Candida Species in Women in Referred to Hamedan Hospitals 2013-2014, West of Iran Zahedan. J Res Med Sci [Internet]. 2016;18(3):e6250. http://dx.doi.org/10.17795/zjrms-6250
Jaqueti J. Epidemiología y etiología de la candidiasis vaginal en mujeres españolas e inmigrantes en Fuenlabrada (Madrid). Rev Esp Quimioter [Internet].2020;33(3):187-192. http://dx.doi.org/10.37201/req/099.2019
Colombia. Ministerio de Salud y Protección Social, Colciencias;(2013). Guía de práctica clínica (GPC) para el abordaje sindrómico del diagnóstico y tratamiento de los pacientes con infecciones de transmisión sexua y otras infecciones del tracto genital. Disponible en: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/INEC/IETS/presentacion ITS.pdf
Mtibaa L, et al. Vulvovaginal candidiasis: Etiology, Symptomatology, and Risk Factors. JMM [Internet].2017;27:153-158. http://dx.doi.org/10.1016/j.mycmed.2017.01.003
Zeng X, et al. Risk Factors of Vulvovaginal Candidiasis among Women of Reproductive Age in Xi’an: A Cross-Sectional Study BioMed. Res Int, 2018 Jun 7, Article ID 9703754, 8 pages. http://dx.doi.org/10.1155/2018/9703754
Cassone A. Vulvovaginal Candida albicans Infections: Pathogenesis, Immunity, and Vaccine Prospects. BJOG [Internet]. 2015;122(6):85-794. http://dx.doi.org/10.1111/1471-0528.12994
Miró MS, et al. Vulvovaginal Candidiasis: An old Disease with new Challenges. Rev Iberoam Micol [Internet]. 2017;34(2):65-71. http://dx.doi.org/10.1016/j.riam.2016.11.006
Ozal Mora N. Infecciones del tracto genital inferior: descarga vaginal. Rev Obstet Ginecol Venez [Internet]. 2019;79(2):98-107. Disponible en: https://www.sogvzla.org/wp-content/uploads/2023/03/2019_vol79_num2_7.pdf
Aballéa S, et al. Subjective Health Status and Health Related Quality of Life among Women with Recurrent Vulvovaginal Candidosis (RVVC) in Europe and the USA. Health Qual Life Outcomes [Internet]. 2013 Oct 11;11:169. http://dx.doi.org/10.1186/1477-7525-11-169
Ignjatović A, et al. Recurrent Vulvovaginal Candidosis and Cluster Analysis of Clinical Signs and Symptoms: A Laboratory-Based Investigation. J Fungi [Internet]. 2020;6(113):1-9. http://dx.doi.org/10.3390/jof6030113
Copyright (c) 2023 Revista Med
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
